(Press-News.org) JACKSONVILLE, Fla. — A new study led by Mayo Clinic found that postmenopausal women receiving menopausal hormone therapy lost 35% more weight while taking tirzepatide, a Food and Drug Administration-approved drug for the treatment of overweight and obesity. The findings, published in The Lancet Obstetrics, Gynaecology, & Women's Health, could expand treatment possibilities for millions of women struggling with obesity and obesity-related diseases after menopause.
Menopause can accelerate age-related weight gain and increase the likelihood of developing overweight and obesity, which are major risk factors for cardiovascular disease, type 2 diabetes and other conditions. The decline in estrogen levels characteristic of menopause is also linked to changes independent of weight that can potentially raise cardiovascular risk. "This study provides important insights for developing more effective and personalized strategies for managing cardiometabolic risk in postmenopausal women," says Regina Castaneda, M.D., postdoctoral research fellow at Mayo Clinic and first author of the study.
Hormone therapy is the most effective first-line treatment for menopausal symptoms, including hot flashes and night sweats, which affect up to 75% of postmenopausal women. While evidence on how this therapy may interact with weight-loss medications is limited, some research has shown that postmenopausal women using hormone therapy experience greater weight loss when treated with the GLP-1-based obesity medication semaglutide.
No previous studies have examined whether hormone therapy might influence outcomes with tirzepatide. Dr. Castaneda and a team of researchers set out to investigate this relationship by reviewing data from 120 participants with overweight or obesity who received tirzepatide for weight management for 12 or more months. Patients receiving tirzepatide along with hormone therapy were compared to participants with similar characteristics who were not using hormone therapy.
"In this observational study, women who used menopausal hormone therapy lost about 35% more weight than women taking tirzepatide alone. Because this was not a randomized trial, we cannot say hormone therapy caused additional weight loss," says Maria Daniela Hurtado Andrade, M.D., Ph.D., endocrinologist at Mayo Clinic and senior author of the study.
"It is possible that women using hormone therapy were already engaged in healthier behaviors, or that menopause symptom relief improved sleep and quality of life, making it easier to stay engaged with dietary and physical activity changes."
Dr. Castaneda says, while more studies that control for these factors are needed, the findings are clinically meaningful. "The magnitude of this difference warrants future studies that could help clarify how GLP-1-based obesity medications and menopausal hormone therapy may interact. Interestingly, preclinical data suggest a potential synergy, with estrogen appearing to enhance the appetite-suppressing effects of GLP-1," says Dr. Castaneda.
"Next, we plan to test these observations in a randomized clinical trial and determine if benefits extend beyond weight loss — specifically, whether hormone therapy also enhances the effects of these medications on cardiometabolic measures," adds Dr. Hurtado Andrade. "If confirmed, this work could speed the development and adoption of new, evidence-based strategies to reduce this risk for millions of postmenopausal women navigating this life stage."
This research was funded by the Mayo Clinic Center for Women's Health Research. Review the study for a complete list of authors, disclosures and funding.
###
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news.
END
New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause
2026-01-23
ELSE PRESS RELEASES FROM THIS DATE:
How molecules move in extreme water environments depends on their shape
2026-01-23
Water behaves in remarkable ways when heated and pressurized beyond its critical point. Under these extreme conditions, known as supercritical water, it no longer acts like an ordinary liquid. Instead, it takes on properties similar to organic solvents, dissolving hydrocarbons efficiently and transporting molecules rapidly. These unique features make supercritical water a promising green medium for energy conversion technologies such as biomass gasification, plastic recycling, and in situ fuel extraction.
Yet many of these reactions occur inside extremely ...
Early-life exposure to a common pollutant harms fish development across generations
2026-01-23
A widely distributed environmental pollutant can leave lasting biological scars that persist long after direct exposure has ended, according to a new study that tracked its effects across multiple generations of fish.
Researchers found that brief exposure to benzo[a]pyrene, a toxic compound produced by fossil fuel combustion and industrial activity, disrupted normal development and skeletal health not only in directly exposed fish but also in their unexposed descendants. The study reveals that these long-term effects are driven by persistent changes in metabolism, shedding new light on how ...
How is your corn growing? Aerial surveillance provides answers
2026-01-22
With already thin profit margins and increasingly uncertain farm labor and other input costs, precision agriculture technology could improve New England’s small and medium-sized farms’ efficiency, productivity, and resilience. Unfortunately, factors such as up-front costs and validation of the technology’s accuracy in the region remain a barrier to adoption. A research team at UNH led by Benjamin Fraser, visiting assistant professor and director of the Basic and Applied Spatial Analysis ...
Center for BrainHealth launches Fourth Annual BrainHealth Week in 2026
2026-01-22
Center for BrainHealth, a global leader in brain health research and its practical application, announces its fourth annual BrainHealth Week, February 23–28, 2026. The week-long conference features a diverse lineup of events designed to educate and inspire people of all ages to take action for better brain health. As brain health takes center stage at global forums like Davos and the UN General Assembly, BrainHealth Week 2026, presented by Ciridian, marks a pivotal moment in cognitive neuroscience. This event brings together world-renowned neuroscientists and brain performance experts to translate breakthrough research into "brain gains." ...
Why some messages are more convincing than others
2026-01-22
What kinds of marketing messages are effective — and what makes people believe certain political slogans more than others? New research from the University of California San Diego Rady School of Management explores how people constantly evaluate whether messages are true or false and finds that a surprisingly small ingredient — whether a word has an easy opposite — can shape how confident people feel when deciding whether a message is true.
“Effective messaging isn’t just about ...
National Foundation for Cancer Research CEO Sujuan Ba Named One of OncoDaily’s 100 Most Influential Oncology CEOs of 2025
2026-01-22
Washington, D.C. | 22 January 2026 – Sujuan Ba, CEO of the National Foundation for Cancer Research (NFCR), has been named to OncoDaily’s list of the 100 Most Influential CEOs in Oncology in 2025, recognizing leaders whose work is shaping the global cancer research and care ecosystem.
The annual list honors chief executives across industry, academia, policy, healthcare systems, and mission-driven organizations whose leadership has driven measurable and lasting impact in oncology worldwide. Dr. Ba is recognized alongside leaders from major cancer centers, biopharmaceutical companies, research institutions, ...
New analysis disputes historic earthquake, tsunami and death toll on Greek island
2026-01-22
For decades, researchers thought that an October 1843 earthquake on the small Greek island of Chalke caused a powerful tsunami and led to the deaths of as many as 600 people.
But a new analysis of primary accounts of the event by Ioanna Triantafyllou at Hellenic Mediterranean University suggests the truth was much less dramatic and destructive.
As Triantafyllou reports in Seismological Research Letters, evidence from primary sources indicates that the mainshock occurred on Chalke on 17 September 1843, causing ...
Drexel study finds early intervention helps most autistic children acquire spoken language
2026-01-22
After receiving evidence-based early interventions, roughly two-thirds of non-speaking kids with autism speak single words, and approximately half develop more complex language, according to a new study led by researchers at Drexel University’s A.J. Drexel Autism Institute. The findings, which offer insights that might help improve success rates for the kids who remain non-speaking or minimally speaking (e.g. not combining words to form short phrases) after therapy, were recently published in the Journal of Clinical Child and Adolescent Psychology.
About one in 31 kids in the United States are autistic, according to a 2025 CDC report, a number that ...
Study finds Alzheimer's disease can be evaluated with brain stimulation
2026-01-22
FOR IMMEDIATE RELEASE, January 22, 2026
Contact: Gina DiGravio, 617-358-7838, ginad@bu.edu
Study Finds Alzheimer's Disease Can Be Evaluated with Brain Stimulation
(Boston)—As individuals with Alzheimer’s disease (AD) move from the mild cognitive impairment stage to moderate and severe dementia, complex awareness deteriorates although lower-level sensory awareness is relatively maintained. Most conscious processes also become more impaired as AD progresses, including attention, working memory, episodic memory and executive function, while unconscious processes, such as ...
Cells that are not our own may unlock secrets about our health
2026-01-22
During pregnancy, maternal and fetal cells migrate back and forth across the placenta, with fetal cells entering the mother’s bloodstream and tissues. They can settle in maternal organs such as the thyroid, liver, lungs, brain and heart — and can persist there for decades. Conversely, maternal cells can enter the fetus and be passed down to future generations, essentially creating a lifelong connection between mothers, their offspring and their descendants.
In other words, we all carry little pieces of our family with us.
This phenomenon, called microchimerism, is often characterized by cells of different genetic origin ...